Key result
Digital health solutions improve engagement and optimize guideline-directed therapy in secondary prevention.
Why the study?
Poor adherence limits the long-term benefits of effective cardiovascular disease treatments, and digital health solutions may enhance optimisation of guideline-based therapies.
Do digital health solutions improve adherence and optimize guideline-based care in patients requiring secondary cardiovascular prevention?
Do digital health solutions improve adherence and optimize guideline-based care in patients requiring secondary cardiovascular prevention?
Digital health solutions offer significant potential to close the evidence-practice gap in secondary cardiovascular prevention, though robust pragmatic trials are needed to confirm long-term clinical benefits.
May support workflow integration in secondary prevention; leaves open hard-endpoint confirmation in large RCTs.
Cardiovascular disease is the leading cause of morbidity and mortality globally. Despite effective treatments, poor adherence limits their long-term benefits. Digital health solutions can enhance clinicians' ability to optimise guideline-based therapies, improving patient outcomes. Digital tools for remote consultations, monitoring, cardiac device interrogation and clinical decision support systems are now widely available. Digital health monitoring improves care quality, providing value to patients, healthcare professionals, hospitals and governments. This transformation is fostering a future where 'health' takes precedence over 'reactive care', driven by empowered patients and advanced technologies. Success in this transformation requires not only technology, but also new strategic operational models, optimised workflows and workforce redesign. Health systems that form partnerships with other stakeholders, such as peers, payers, start-ups, life sciences organisations, industries, will be better positioned to improve patient experiences and outcomes. This review examines digital solutions that optimise medical therapy prescriptions, promote patient engagement and address therapeutic inertia in AF, heart failure and coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Monaco et al. (2026) conducted a review in Cardiovascular disease. Digital health solutions vs. Standard care was evaluated. Digital health solutions can enhance patient engagement and optimize guideline-based therapies in secondary cardiovascular prevention, though large randomized studies with hard endpoints are needed.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: